Optimization of DOAC management services in a centralized anticoagulation clinic
- PMID: 35541695
- PMCID: PMC9069544
- DOI: 10.1002/rth2.12696
Optimization of DOAC management services in a centralized anticoagulation clinic
Abstract
Background: In 2017, the Brigham and Women's Hospital Anticoagulation Management Service (BWH AMS) expanded services to patients on direct oral anticoagulants (DOACs). We have since updated our DOAC management plan and adjusted the workflow of our clinic.
Objectives: This report describes how our DOAC management has evolved and describes key interventions made. Additionally, we report on the results of a survey completed by referring physicians that assessed perspectives regarding centralized DOAC management by BWH AMS pharmacists.
Methods: An analysis was completed of all patients referred to the BWH AMS and the number of interventions completed and documented in our anticoagulation management software. A survey with eight questions was sent to 110 referring physicians (selected based on referring to the AMS within the past 1.5 years).
Results: Over 4 years, 1622 patients on DOACs were referred to the BWH AMS, amounting to 3154 DOAC encounters. A total of 212 interventions for medication procurement, 171 dose adjustment interventions, and 603 coordinated procedure plans were completed. Of the 32 physicians who responded to the survey, many believed that the quality and safety of anticoagulation therapy was improved with BWH AMS management. Despite provider satisfaction with pharmacist-led care in DOACs, physicians expressed concerns regarding the lack of provider awareness of the clinic and possible duplicative efforts.
Conclusion: We plan to evolve the DOAC clinic model to optimize its clinical and operational value and to improve our delivery of care using electronic tools to move toward a population management approach for DOAC management.
Keywords: anticoagulant; burnout; clinical pharmacy services; direct‐acting oral anticoagulant; quality improvement.
© 2022 The Authors. Research and Practice in Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis (ISTH).
Figures
References
-
- Institute of Safe Medication Practices . Quarterly Watch‐25. Institute of Safe Medication Practices; 2015.
-
- The Joint Commission . National Patient Safety Goal for anticoagulant therapy. R3 Report. 2018;(19):1‐4.
-
- Managing the risks of direct oral anticoagulants. Sentinel Event Alert. July 30, 2019;(61):1‐5.
-
- Larock A‐S, Mullier F, Sennesael A‐L, et al. Appropriateness of prescribing dabigatran etexilate and rivaroxaban in patients with nonvalvular atrial fibrillation: a prospective study. Ann Pharmacother. 2014;48(10):1258‐1268. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous
